181 related articles for article (PubMed ID: 14606276)
1. Imiquimod: mode of action and therapeutic potential.
Chosidow O; Dummer R
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):8-11. PubMed ID: 14606276
[No Abstract] [Full Text] [Related]
2. Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.
Miller R
Int J Dermatol; 2002 May; 41 Suppl 1():3-6. PubMed ID: 12087815
[No Abstract] [Full Text] [Related]
3. Imiquimod in dermatology: an overview.
Hanna E; Abadi R; Abbas O
Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
5. Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.
Papadavid E; Stratigos AJ; Falagas ME
Expert Opin Pharmacother; 2007 Aug; 8(11):1743-55. PubMed ID: 17685890
[TBL] [Abstract][Full Text] [Related]
6. [Pharma clinics. Medication of the month. Imiquimod (Aldara): an immunomodulator for the skin].
Hermanns-Lê T; Nikkels AF; Uhoda I; Petit L; Piérard GE
Rev Med Liege; 2002 Feb; 57(2):116-8. PubMed ID: 11942177
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
8. To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream.
Rivera A; Markus J; Pielop JA; Orengo I
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1481-2. PubMed ID: 16416627
[No Abstract] [Full Text] [Related]
9. Imiquimod in basal cell carcinoma: how does it work?
Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
[TBL] [Abstract][Full Text] [Related]
10. Current and potential uses of imiquimod.
Chang YC; Madkan V; Cook-Norris R; Sra K; Tyring S
South Med J; 2005 Sep; 98(9):914-20. PubMed ID: 16217984
[TBL] [Abstract][Full Text] [Related]
11. Beyond a decade of 5% imiquimod topical therapy.
A Gaspari A; Tyring SK; Rosen T
J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod.
Jobanputra KS; Rajpal AV; Nagpur NG
Indian J Dermatol Venereol Leprol; 2006; 72(6):466-9. PubMed ID: 17179631
[No Abstract] [Full Text] [Related]
13. Imiquimod.
Wooten JM
South Med J; 2005 Sep; 98(9):852. PubMed ID: 16217974
[No Abstract] [Full Text] [Related]
14. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential.
Stanley MA
Clin Exp Dermatol; 2002 Oct; 27(7):571-7. PubMed ID: 12464152
[TBL] [Abstract][Full Text] [Related]
15. [Imiquimod--a substance with a broad working spectrum].
Oster-Schmidt C
J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584
[No Abstract] [Full Text] [Related]
16. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Berman B
Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
[No Abstract] [Full Text] [Related]
17. Treatment of non-melanoma skin cancer: immunotherapy as a viable option.
Shumack S; Rigel D
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):18-22. PubMed ID: 14606278
[No Abstract] [Full Text] [Related]
18. Imiquimod 5% cream: a new treatment option for basal cell carcinoma.
Salasche S
Int J Dermatol; 2002 May; 41 Suppl 1():16-20. PubMed ID: 12087814
[No Abstract] [Full Text] [Related]
19. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
20. [How I treat ... basal cell carcinoma by imiquimod].
Piérard-Franchimont C; Nikkels AF; Paquet P; Quatresooz P; Piérard GE
Rev Med Liege; 2005 Apr; 60(4):207-9. PubMed ID: 15943094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
